About Pragya Pandey
Pragya is an equity research analyst and financial journalist with a passion for investing. In college she majored in finance and is currently pursuing the CFA program and is a Level II candidate.
When analyzing stocks, Pragya takes a fundamental approach and focuses on measuring a company's intrinsic value. Her goal is to help retail investors create successful portfolios to achieve financial success.
Recent Articles By Pragya Pandey
This 1 Energy Company Could See Some Significant Upside in the Near Term
Shares of Shell Plc (SHEL) have slumped nearly 17.8% over the past month. However, given the rising oil prices, company-wide strategic advances, and partnerships, SHEL is expected to witness significant upside in the coming months. Read on to learn more...
Why This Home Builder Stock Could Make a Great Long-Term Buy
Despite increasing interest rates, D.R. Horton (DHI) continues to garner investor attention based on its strong fundamentals and stable growth prospects. In addition, the company’s recent acquisition could further assist it in achieving solid long-term growth and delivering robust shareholder returns. Read on...
Should Investors Buy This Specialty Retail Stock as It Looks to Cut Staff?
While GameStop (GME) reported stable top-line growth in its last earnings, the recent announcement about cutting the workforce raised questions regarding its prospects. In addition, given the company's poor earnings growth prospects and pessimistic analyst outlook, can GME be able to maintain its market standing? Let’s find out...
BofA Upgrades This 1 Beverage Company to “Buy.” Is Now the Time to Get In?
The shares of The Vita Coco Company (COCO) have garnered significant investor attention after the recent ratings upgrade from BofA over stabilizing freight costs. So, let’s evaluate if it is worth buying the stock now, given the rising competition in the beverages industry. Read on...
WD-40 Tumbles Following Lowered Guidance. Should Investors Consider Selling the Stock?
WD-40 Company (WDFC) reported negative earnings and sales growth in the last quarter. In addition, the company lowered its guidance for fiscal 2022, further adding to investors’ concerns. So, let’s evaluate if it is worth adding the stock to your portfolio now. Read on to learn more…
1 Consumer Staple Stock That Still Has Room for More Upside
Renowned non-alcoholic beverage company Coca-Cola (KO) has skillfully navigated an inflation-ravaged market and gained nearly 7% year-to-date. With continued advancements to strengthen its brand offerings and improve its segmental performance, the company is poised to witness significant upside in the near term. Read on…
Is This "Strong Buy" Health Insurance Company a Bargain?
Healthcare company Elevance Health (ELV) reported solid revenue growth in the last reported quarter. While the stock trades at a discount to its peers, analysts expect the company’s financials to improve. So, let’s evaluate if it would be wise to buy the stock now. Read on...
Is This "Strong Buy" Health Insurance Company A Bargain?
Healthcare company Elevance Health (ELV) reported solid revenue growth in the last reported quarter. While the stock trades at a discount to its peers, analysts expect the company’s financials to improve. So, let’s evaluate if it would be wise to buy the stock now. Read on...
Is This "Strong Buy" Health Insurance Company A Bargain?
Healthcare company Elevance Health (ELV) reported solid revenue growth in the last reported quarter. While the stock trades at a discount to its peers, analysts expect the company’s financials to improve. So, let’s evaluate if it would be wise to buy the stock now. Read on...